Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
27
result was found. Results that relate to
ZHANG Ya
Clinical observation of omadacycline in treating elderly patients with chronic obstructive pulmonary disease complicated by community-acquired bacterial pneumonia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(8):1385-1392.
6467 times
1129 times
YANG Feiyan
YANG Guobiao
ZHANG Ya
YANG Jianye
XU Mengmin
Omadacycline
Chronic obstructive pulmonary disease
Community-acquired bacterial pneumonia
Clinical efficacy
Details
The association between sleep duration, overweight/obesity, and multimorbidity among primary care medical staff
Published on
New Medicine
2025,35(9):1004-1010.
11717 times
1327 times
JIANG Hong
LEI Haoyuan
GENG Hui
HE Dandan
ZHANG Ya
nxiu
MA Mao
Multimorbidity
Sleep duration
Overweight/obesity
Medical staff of primary health service institutions
Details
The effect of combined photodynamic therapy with α-melittin-PPIX-NP on the biological behavior of B16-F10 cells
Published on
New Medicine
2025,35(9):1048-1056.
9832 times
1214 times
LI Sanrong
ZHANG Ya
n
XIAO Min
GENG Yuanyuan
Melittin
Photodynamic therapy
Melanoma
Hemolysis of red blood cells
SR-B1 receptor
Cell apoptosis
Bone marrow-derived dendritic cells
Details
Expert consensus for off-label drug use of rare disease: a protocol
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(9):1066-1073.
6447 times
1346 times
CHEN Chaoyang
DUAN Yuehan
ZHUO Lin
HE Guohua
ZHANG Ya
nqin
ZHOU Ying
WANG Shengfeng
CUI Yimin
DING Jie
Rare disease
Off-label use
Expert consensus
Study protocol
Details
Challenges and new advances in antitubercular drug therapy for renal transplant recipients
Published on
Frontiers in Pharmaceutical Sciences
2025,29(11):1975-1980.
6103 times
972 times
ZHANG Wei
ZHANG Ya
xin
LIU Yuanyuan
YAN yan
SUN Kun
JI Zhaoshuai
Renal transplantation
Tuberculosis
Drug-drug interactions
Pharmacotherapy
Drug-resistant tuberculosis
Recent progress in therapy
Details
Comprehensive analysis of quality markers for Xiaoding ointment based on multi-dimensional feature fusion
Published on
Frontiers in Pharmaceutical Sciences
2026,30(1):12-22.
3258 times
680 times
CHANG Dengxi
LI Wenxia
DAI Haoen
ZHANG Ya
n
CHANG Chengdong
Xiaoding ointment
Multi-dimensional feature network
Quality marker
Component analysis
Molecular docking
Quality control
Pharmacological effects
Details
Latent profile analysis of health empowerment in elderly patients with ischemic stroke
Published on
Journal of Mathematical Medicine
2026,39(2):132-140.
3348 times
758 times
WANG Jingxue
LIU Yamei
BIAN Xiaoxiao
LIANG Zehua
XUE Wenhan
WANG Chen
WANG Hao
ZHANG Ya
nju
LI Xianghua
Ischemic stroke
Elderly patients
Health empowerment
Latent profile analysis
Details
Analysis of inorganic elements in Aconitum vilmorinianum Kom. by ICP-MS combined with chemometric methods
Published on
Frontiers in Pharmaceutical Sciences
2026,30(3):412-422.
2669 times
668 times
ZHANG Ya
nming
LIU Yingying
LIU Yi
LIU Chengya
HUANG Lijia
PU Lianxin
LI Zhiyuan
Aconitum vilmorinianum Kom.
Inorganic elements
Microwave digestion
Inductively coupled plasma mass spectrometry
Chemometrics
Content determination
Analysis
Geographical origin
Details
Analysis of the safety profile of zavegepant based on the FAERS database and comparison with CGRP-targeted drugs
Published on
Frontiers in Pharmaceutical Sciences
2026,30(3):455-465.
2894 times
574 times
XIE Jinlian
WANG Qing
ZHANG Xingfei
ZHANG Ya
xin
WU Qian
MA Junlong
KUANG Yun
GUO Chengxian
Calcitonin gene-related peptide-targeted medication
Zavegepant
FAERS database
Signal mining
Disproportionality analysis
Bayesian confidence propagation neural network
Adverse events
Pharmacovigilance
Details
Analysis of the molecular mechanism and miRNA–mRNA regulatory network of henagliflozin in diabetic kidney disease based on machine learning
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(4):409-418.
1391 times
388 times
CHENG Si
ZHANG Ya
nping
LIU Xin
WANG Fei
ZHAO Jindong
FANG Zhaohui
Henagliflozin
Diabetic kidney disease
miRNA-mRNA regulatory network
Differentially expressed genes
Machine learning
Details
Mechanism of formulas containing the Astragali Radix-Anemarrhenae Rhizoma herb pair in treating chronic heart failure based on Apriori algorithm, network pharmacology, and molecular docking
Published on
Frontiers in Pharmaceutical Sciences
2026,30(4):541-554.
2326 times
528 times
ZHANG Mengqian
PANG Jianying
WANG Chaohui
HOU Jiahao
ZHANG Ya
jing
LI Jing
SONG Yongxing
MA Donglai
Chronic heart failure
Astragali Radix-Anemarrhenae Rhizoma
Herb pair
Apriori algorithm
Network pharmacology
Molecular docking
Details
Simultaneous determination of 10 impurities in ibuprofen and its preparations by UPLC method
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):804-812.
877 times
165 times
YUN Xiaofei
ZHANG Ya
nxia
QIAN Yujuan
HAN Feng
XIAO Honghua
YAN Zeman
WANG Meng
Ibuprofen
Ultra-performance liquid chromatography
Impurities
Toxicity
Quality control
Details
上一页
1
2